Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Morgensztern

Showing results (71-80 of 184) with videos related to

Pageof 19
Sort By:
Acta Haematologica|October 10, 2002
Warm-antibody autoimmune hemolytic anemia developing after thrombotic thrombocytopenic purpuraDaniel Morgensztern, Mohamed A Kharfan-Dabaja, Han-Mou Tsai, et al.
Leukemia & Lymphoma|August 19, 2007
Rituximab for treatment of chemoimmunotherapy naive marginal zone lymphomaIzidore S Lossos, Daniel Morgensztern, Marcelo Blaya, et al.
Chemotherapy|January 19, 2016
A Phase I Trial of Temsirolimus and Pemetrexed in Patients with Advanced Non-Small Cell Lung CancerSaiama N Waqar, Maria Q Baggstrom, Daniel Morgensztern, et al.
BMC Endocrine Disorders|April 5, 2020
Effect of metastatic site on survival in patients with neuroendocrine neoplasms (NENs). An analysis of SEER data from 2010 to 2014Nikolaos A Trikalinos, Benjamin R Tan, Manik Amin, et al.
Leukemia & Lymphoma|December 29, 2004
Combination of imatinib and cytarabine for the treatment of Philadelphia chromosome positive acute lymphoblastic leukemiaDaniel Morgensztern, Manuel F Rosado, Luis E Raez, et al.
American Journal of Hematology|July 30, 2004
Heparin-induced thrombocytopenia presenting with thrombosis of multiple saphenous vein grafts and myocardial infarctionErnesto Ayala, Manuel F Rosado, Daniel Morgensztern, et al.
The American Journal of Gastroenterology|December 23, 2003
Primary hepatic non-Hodgkin's lymphomas: case report and review of the literatureEdgardo S Santos, Luis E Raez, Jorge Salvatierra, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 26, 2009
Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysisJanakiraman Subramanian, Daniel Morgensztern, Boone Goodgame, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2015
Reply to C. Le Péchoux et al and B.S. Gill et alCliff G Robinson, Aalok P Patel, Todd DeWees, et al.
Lung Cancer (Amsterdam, Netherlands)|May 22, 2020
SC-002 in patients with relapsed or refractory small cell lung cancer and large cell neuroendocrine carcinoma: Phase 1 studyDaniel Morgensztern, Melissa Johnson, Charles M Rudin, et al.
Pageof 19

Showing results (71-80 of 184) with videos related to

Sort By:
Pageof 19
Acta Haematologica|October 10, 2002
Warm-antibody autoimmune hemolytic anemia developing after thrombotic thrombocytopenic purpuraDaniel Morgensztern, Mohamed A Kharfan-Dabaja, Han-Mou Tsai, et al.
Leukemia & Lymphoma|August 19, 2007
Rituximab for treatment of chemoimmunotherapy naive marginal zone lymphomaIzidore S Lossos, Daniel Morgensztern, Marcelo Blaya, et al.
Chemotherapy|January 19, 2016
A Phase I Trial of Temsirolimus and Pemetrexed in Patients with Advanced Non-Small Cell Lung CancerSaiama N Waqar, Maria Q Baggstrom, Daniel Morgensztern, et al.
BMC Endocrine Disorders|April 5, 2020
Effect of metastatic site on survival in patients with neuroendocrine neoplasms (NENs). An analysis of SEER data from 2010 to 2014Nikolaos A Trikalinos, Benjamin R Tan, Manik Amin, et al.
Leukemia & Lymphoma|December 29, 2004
Combination of imatinib and cytarabine for the treatment of Philadelphia chromosome positive acute lymphoblastic leukemiaDaniel Morgensztern, Manuel F Rosado, Luis E Raez, et al.
American Journal of Hematology|July 30, 2004
Heparin-induced thrombocytopenia presenting with thrombosis of multiple saphenous vein grafts and myocardial infarctionErnesto Ayala, Manuel F Rosado, Daniel Morgensztern, et al.
The American Journal of Gastroenterology|December 23, 2003
Primary hepatic non-Hodgkin's lymphomas: case report and review of the literatureEdgardo S Santos, Luis E Raez, Jorge Salvatierra, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 26, 2009
Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysisJanakiraman Subramanian, Daniel Morgensztern, Boone Goodgame, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2015
Reply to C. Le Péchoux et al and B.S. Gill et alCliff G Robinson, Aalok P Patel, Todd DeWees, et al.
Lung Cancer (Amsterdam, Netherlands)|May 22, 2020
SC-002 in patients with relapsed or refractory small cell lung cancer and large cell neuroendocrine carcinoma: Phase 1 studyDaniel Morgensztern, Melissa Johnson, Charles M Rudin, et al.
Pageof 19